23 July 2014: TranScrip Partners announce the appointment of a Chief Operating Officer, Anne Hancock.
TranScrip are delighted to announce the appointment of Anne Hancock as the new Chief Operating Officer. Anne has over 30 years’ experience in clinical development including senior positions in a variety of companies. She has been in substantial roles in large Pharma (ICI now AZ as Project Director), CRO (ClinTrials as Director of Project Management and Quintiles as Senior Project Management Director), Medical devices (Vidamed as Director of Clinical Affairs) and small biotech and funding organisations (Celtic). She is well used to managing big groups of people during the challenges of rapid growth.
Anne will lead TranScrip’s global operational teams supporting the partner organisation and the next phase of the partnerships growth. Her experience in the services sector will be invaluable as well as her depth of understanding of working in both big pharma and biotech to achieve completion of complex projects.
Managing Partner, Flic Gabbay said “Anne will be an enormous asset to TranScrip and we are very much looking forward to organizational support. Her appointment represents another critical milestone in TranScrip’s continuing growth.”